Amgen Inc. (AMGN)
Piper Jaffray analyst Barbara Hoffman said the newly published American Society of Clinical Oncology clinical practice guidelines on the use of colony stimulating factors will have a neutral impact overall on AMGN's Neupogen G-CSF.